Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group

American Journal of Hypertension

Volumn 25, Issue 5, 2012, Pages 561-567

  Wong, Nathan D ^a   Dede, Jennifer ^a   Chow, Vincent H ^a   Wong, Ken S ^b   Franklin, Stanley S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

blood pressure; cardiovascular disease; epidemiology; global risk; hypertension; risk factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SODIUM RESTRICTION; WEIGHT REDUCTION;

ADULT; AGED; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NUTRITION SURVEYS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84859926166     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2012.2     Document Type: Article

References (21)

1. Franklin SS, Wong ND. Cardiovascular risk evaluation: an inexact science. J Hypertens 2002; 20:2127-2130. (Pubitemid 35388224)
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
3. Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S. Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens 2009; 22:273-280.
4. Jackson R. Attributing risk to hypertension: what does it mean? Am J Hypertens 2009; 22:237-238.
5. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49:69-75. (Pubitemid 46360343)
6. Qureshi AI, Suri MF, Kirmani JF, Civani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976-2000.
7. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B; PRATIK study investigators. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study). J Hypertens 2002; 20:779-784. (Pubitemid 34913724)
8. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20:1297-1302. (Pubitemid 34925673)
9. Fagard RH, Van den Enden M. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care. J Hum Hypertens 2003; 17:681-687. (Pubitemid 37265144)
10. Wong ND, Lopez VA, L'Italien G, Chen R, Kline SEJ, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007; 167: 2437-2442.
11. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753. (Pubitemid 351640675)
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762. (Pubitemid 47356612)
13. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition examination Survey Laboratory/Medical Technologists Procedures Manual Hyattsville, MD: US Department of Health and Human Services, Center for Disease Control and Prevention: 2003-2004.
14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
16. Shah BV, Barnwell BG. SUDAAN Users' Manual Release 7.5. Research Triangle Institute: Cary, NC, 1997.
17. SAS Procedures Guide. Version 6.12. 3rd ed. SAS Institute: Cary, NC, 1995.
18. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004; 22:51-57. (Pubitemid 38293530)
19. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, Menotti A, Zanchetti A, Mancia G. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25:1491-1498. (Pubitemid 46918838)
20. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes 2010; 3:8-14.
21. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180-187. (Pubitemid 32640849)